IDEXX reports Q2 growth in revenue, earnings, and raises guidance

Westbrook-based IDEXX Laboratories Inc. (Nasdaq: IDXX) on Friday morning reported revenue of $826 million during the year’s second quarter, an increase over the same period in 2020 of 30% on a reported basis and 26% organically.

IDEXX, which makes veterinary diagnostic tools and practice software as well as water microbiology tests, reported earnings per share of $2.34. That represented 36% growth as reported and 33% on a comparable basis, and exceeded the consensus estimate by Zacks Investment Research of $2.01. Read more

Related Posts

On the Record: Roux Institute’s Lars Perkins helps startups take off

Lars Perkins, a former software entrepreneur, Google executive and certified flight instructor who once flew planes for lifesaving “adventure philanthropy,” is managing...

28 November 2022

UNE to begin building new medical school at Portland campus

The University of New England is about to start a $93 million project to move the state’s only medical school from...

28 November 2022

Portland Planning Board recommends zoning changes for Roux Institute redevelopment

The Portland Planning Board is recommending that the city adopt zoning changes requested by the developers of a new graduate school...

22 November 2022